BofA raised the firm’s price target on Marsh McLennan (MMC) to $246 from $236 and keeps a Neutral rating on the shares. The firm is updating its price targets for U.S. Insurance companies under its coverage, the analyst tells investors. Q3 turned out to be a “relatively calm” season without any hurricanes making landfall in the U.S. and, while 1H saw elevated levels of macro uncertainties, this did not translate to material adverse impact on earnings, the firm says.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MMC:
- Marsh McLennan upgraded to Overweight from Neutral at JPMorgan
- Marsh McLennan price target lowered to $257 from $258 at UBS
- Marsh McLennan price target lowered to $221 from $233 at Barclays
- Marsh McLennan price target lowered to $215 from $220 at Morgan Stanley
- Marsh McLennan price target lowered to $209 from $210 at Keefe Bruyette